-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, STISTjZk6iZTk+j+uGp0Ycme7XyE0ZVF27lDog8rbWDDABmkN6++panMADX5VkcN OaHr/miHplmcWBpD5uVj3Q== 0001181431-05-018387.txt : 20050323 0001181431-05-018387.hdr.sgml : 20050323 20050323192216 ACCESSION NUMBER: 0001181431-05-018387 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050321 FILED AS OF DATE: 20050323 DATE AS OF CHANGE: 20050323 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: V I TECHNOLOGIES INC CENTRAL INDEX KEY: 0001040017 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 113238476 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 134 COOLIDGE AVE CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 5167527314 MAIL ADDRESS: STREET 1: 134 COOLIDGE AVE CITY: WATERTOWN STATE: MA ZIP: 02472 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LINSLEY ERIC W CENTRAL INDEX KEY: 0001320179 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24241 FILM NUMBER: 05700146 BUSINESS ADDRESS: BUSINESS PHONE: 9199983300 MAIL ADDRESS: STREET 1: 7030 KIT CREEK ROAD STREET 2: P.O. BOX 110287 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 4 1 rrd73406.xml FORM 4 FOR 3 21 05 X0202 4 2005-03-21 0 0001040017 V I TECHNOLOGIES INC VITXD 0001320179 LINSLEY ERIC W A.M. PAPPAS & ASSOCIATES, LLC 7030 KIT CREEK ROAD RESEARCH TRIANGLE PARK NC 27709 1 0 1 0 Common stock 1220 D Common stock 5791572 I See footnote 2 On March 21, 2005, A.M. Pappas Life Science Ventures I, L.P. (the "Fund") distributed 380,000 shares of V.I. Technologies, Inc. to its partners for no consideration. The reporting person, as a limited partner, received 1,166 shares. Because the reporting person has been attributed with beneficial ownership of these shares of the issuer's stock, this transaction constitutes a mere change in the form of beneficial ownership. 5,787,609 shares are directly held by A.M. Pappas Life Science Ventures I, L.P. ("PV I"), which has a general partner, AMP&A Management, LLC ("Management"), which is managed by A.M. Pappas & Associates, LLC ("AMP&A"). 3,963 shares are now held directly by Management after the distribution described in footnote 1. AMP&A may be deemed a beneficial owner of these securities. The reporting person is a member of AMP&A and, as a result, may also be deemed a beneficial owner of these securities. The reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that this person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Reported on a post-split basis. /s/ John R. Barr (pursuant to power-of-attorney) 2005-03-23 -----END PRIVACY-ENHANCED MESSAGE-----